McKesson Corp (MCK)

Data as of 2026-09-03.

Key facts

Price
925.21 USD
Market capitalisation
$104.2B
P/E ratio
24.1
Dividend yield
0.27%
52-week range
682.35 - 999.00
Beta
0.30
Sector
Health Care
Industry
Health Care
Country
US
Exchange
NEW YORK STOCK EXCHANGE, INC.
Employees
43 000
IPO date
1994-11-10
Analyst price target
1002.00 USD
Analyst consensus
20 buy / 3 hold / 0 sell
Stoxly score
64.2 / 100
Universe percentile
better than 72% of the analysed universe

About McKesson Corp

McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.

Website

Similar companies

Full Quality Check for McKesson Corp

Stoxly scores rate the quality of the published fundamentals, not the upside of the share price. Nothing on this page is investment advice.